Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000294773

Medchemexpress LLC 5-(hexahydropyrrolo[1,2-a]pyrazine-2-carbonyl)-4-chloro-2-fluoro-N-(2-fluorophenyl)benzenesulfonamide | 1235560-28-7 | MFCD29924737 | 99.3% | 457.48 g/mol | C20H20ClF2N3O3S | 10 MG
SDP

Catalog No. 5000294773
Encompass_Preferred

ABT-639 is a peripherally acting, selective T-type Ca2+ (CaV3.2) calcium channel blocker supplied as a research reagent. It has been investigated for analgesic and antihyperalgesic activity in preclinical and clinical studies and is provided as a high-purity solid for laboratory use.

  • Peripherally acting T-type Ca2+ channel blocker.
  • Selective for CaV3.2 T-type channels.
  • High purity suitable for research applications.
  • Supplied as a solid, convenient for formulation and dosing.
  • Intended for in vitro and in vivo research use; not for human use.

Catalog No. 50-002-94773 Supplier Medchemexpress LLC Supplier No. HY1972110MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ABT-639 is a peripherally acting, selective T-type Ca2+ (CaV3.2) calcium channel blocker supplied as a research reagent. It has been investigated for analgesic and antihyperalgesic activity in preclinical and clinical studies and is provided as a high-purity solid for laboratory use.

  • Peripherally acting T-type Ca2+ channel blocker.
  • Selective for CaV3.2 T-type channels.
  • High purity suitable for research applications.
  • Supplied as a solid, convenient for formulation and dosing.
  • Intended for in vitro and in vivo research use; not for human use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.